Sharenet Sites 
Sharenet Sites
Dealings in securities by directors, prescribed officers, the company secretary and the JSE LTIS 2018 Trust
JSE LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 2005/022939/06
Share Code: JSE
ISIN: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
("JSE")
DEALINGS IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS, THE COMPANY
SECRETARY AND THE JSE LTIS 2018 TRUST
The JSE LTIS 2018 Trust ("Trust") has acquired 756 828 JSE ordinary shares
in the open market on behalf of executive directors, prescribed officers,
the Company Secretary, and senior members of staff ("LTIS 2018
participants") in respect of share awards granted in March 2023 to these
LTIS 2018 participants under the JSE’s Long-Term Incentive Scheme ("LTIS
2018"). The ordinary shares are held by the LTIS 2018 participants on a
direct beneficial basis.
These ordinary shares are restricted until all vesting criteria are
fulfilled whereupon the shares will vest in the hands of LTIS 2018
participants. To the extent that the vesting criteria are not fulfilled,
the share awards are forfeited.
The vesting of these restricted JSE ordinary shares is subject to –
(i) the JSE achieving specified corporate performance targets over the
measurement period; and
(ii) the LTIS 2018 participant remaining in the employ of the JSE for the
vesting term (collectively "the vesting criteria").
These JSE ordinary shares were acquired on-market, with prior clearance and
at a volume-weighted average price (“VWAP”) of R104.726625 per ordinary
share. The total transaction value amounted to R79 260 042. The daily high,
low and volume-weighted average price for the various transactions effected
by the Trust were –
Dates in 2023 Daily VWAP of
that JSE Number of JSE JSE shares Daily highest Daily lowest
ordinary ordinary acquired price paid price paid
shares were shares (cents per (cents per (cents per
acquired acquired share) share) share)
15 March 77 861 10298.89 10310 10180
16 March 678 967 10492.59 10500 10377
The requisite approvals have been granted by shareholders at the JSE’s
annual general meeting, in respect of the acquisition of JSE ordinary shares
in the open market and in respect of specific financial assistance to the
Trust for the purpose of acquiring these ordinary shares.
ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS
AND THE COMPANY SECRETARY
Following the acquisition of the JSE ordinary shares by the Trust as
disclosed above, the executive directors, the prescribed officers and the
Company Secretary have, on 20 March 2023, accepted grants of restricted JSE
ordinary shares, as reflected below.
Total number
of restricted Total Rand value
JSE ordinary of restricted JSE
shares ordinary shares
awarded and awarded and Nature of
Executive Role accepted accepted interest
Group CEO & Direct
L Fourie Executive 125 468 13 139 840 beneficial
Director
Group CFO &
Executive Direct
F Suliman Director 54 892 5 748 653 beneficial
Prescribed Direct
A Greenwood Officer 54 892 5 748 653 beneficial
Prescribed Direct
V Lee Officer 29 214 3 059 483 beneficial
Prescribed Direct
I Monale Officer 40 711 4 263 525 beneficial
Prescribed Direct
Q Mthembu Officer 19 029 1 992 842 beneficial
Prescribed Direct
M Randall Officer 46 192 4 837 532 beneficial
Prescribed Direct
T Tsoaeli Officer 41 169 4 311 490 beneficial
Prescribed Direct
V Reddy Officer 60 991 6 387 381 beneficial
Group Company Direct
GA Brookes Secretary 13 794 1 444 599 beneficial
The restricted shares will vest in two tranches, one-half on 1 March 2026
and the remaining half on 1 March 2027, subject to the vesting criteria as
set out above being met.
The individual allocations (grant and acceptance) were approved by the JSE’s
Group Remuneration Committee and clearance to deal was granted by the
Chairman of the Board.
Sandton
20 March 2023
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 20-03-2023 05:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
